Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ULTRA: Ultra-early Tranexamic Acid in Subarachnoid Hemorrhage
NCT02684812Phase 3Completed
- Sponsor
- University of Amsterdam
- Start
- Jul 2012
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tranexamic acid in subarachnoid hemorrhage (SAH) (2 arms), sponsored by University of Amsterdam. Primary endpoint: Modified Rankin Scale at 6 months. Started Jul 2012; status: completed.
02
Drugs
tranexamic acid
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT02684812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02684812.